wsbdaily | Tue, 20 Dec 2022 03:11:26 EST Where you find Tomorrow’s Hot Stocks Yesterday!
NOT INVESTMENT ADVICE: ALL CONTENT IS PROVIDED 'AS IS' FOR ENTERTAINMENT AND/OR INFORMATIONAL PURPOSES ONLY.
WITHOUT WARRANTY OF ANY KIND. YOU BEAR ALL RISKS, INCLUDING ANY RELIANCE ON THE ACCURACY OF ANY INFORMATION.
WE ARE NOT AFFILIATED WITH THE WALLSTREETBETS NOR ANY OTHER COMMUNITY ON REDDIT.
WITHOUT WARRANTY OF ANY KIND. YOU BEAR ALL RISKS, INCLUDING ANY RELIANCE ON THE ACCURACY OF ANY INFORMATION.
WE ARE NOT AFFILIATED WITH THE WALLSTREETBETS NOR ANY OTHER COMMUNITY ON REDDIT.
Johnson & Johnson(JNJ)
Johnson & Johnson
One Johnson & Johnson Plaza
New Brunswick, NJ 08933
United States
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC... Read More
Summary & Charts
| Price | $ 178.00 | +1.91 (+1.08%) |
| Day's Range | $ 174.78 - 178.00 | |
| Previous Close | $ 176.09 | |
| Market Cap | $ 465.38B USD | |
| Short Interest % | N/A | |
| Float | N/A | |
| Outstanding | N/A |
| Exchange | NYSE | |
| Industry | Drug Manufacturers—General | |
| Sector | Healthcare | |
| Volume | 13.28M | |
| Avg. Volume (20 day) | 6.57M | |
| Rel. Volume (20 day) | 2.02 | |
| Rel. Volume (3 month) | 1.87 | |
| Rating | A+ | Strong Buy |
| DCF | N/A | Strong Buy |
| Debt/Equity | 134.75 % | Buy |
| ROE | 25.57 % | Neutral |
| ROA | 14.21 % | Neutral |
| P/E | 25.91 % | Strong Buy |
| P/B | 6.24 % | Strong Buy |
| Date | Open | High | Low | Close | Change | Volume | R. Vol. (20d) | R. Vol. (3m) | Mentions |
|---|---|---|---|---|---|---|---|---|---|
| Nov 30, 2022 | $ 176.37 | $ 178.00 | $ 174.78 | $ 178.00 | +1.91 | 13,282,837 | 2.02 | 1.87 | 2 |
| Nov 29, 2022 | $ 177.01 | $ 177.26 | $ 174.66 | $ 176.09 | -1.24 | 6,700,143 | 1.07 | 0.96 | 2 |
| Nov 28, 2022 | $ 176.75 | $ 177.77 | $ 176.56 | $ 177.33 | +0.09 | 6,183,311 | 0.98 | 0.89 | 3 |
| Nov 25, 2022 | $ 177.38 | $ 178.12 | $ 176.86 | $ 177.24 | +0.23 | 3,058,630 | 0.49 | 0.44 | 3 |
| Nov 23, 2022 | $ 176.44 | $ 177.40 | $ 176.01 | $ 177.01 | +0.19 | 5,389,338 | 0.84 | 0.77 | 2 |
| Nov 22, 2022 | $ 176.40 | $ 177.19 | $ 176.33 | $ 176.82 | +0.85 | 4,708,006 | 0.73 | 0.67 | 2 |
| Nov 21, 2022 | $ 175.89 | $ 176.55 | $ 174.83 | $ 175.97 | -0.23 | 5,706,600 | 0.88 | 0.79 | 3 |
| Nov 18, 2022 | $ 175.00 | $ 176.64 | $ 174.62 | $ 176.20 | +1.34 | 6,554,300 | 1.00 | 0.91 | 12 |
| Nov 17, 2022 | $ 173.00 | $ 174.99 | $ 172.98 | $ 174.86 | +1.40 | 4,464,100 | 0.67 | 0.62 | 2 |
| Nov 16, 2022 | $ 173.64 | $ 174.99 | $ 173.13 | $ 173.46 | +1.07 | 5,500,900 | 0.82 | 0.77 | 4 |
| Nov 15, 2022 | $ 172.19 | $ 173.00 | $ 170.52 | $ 172.39 | +0.48 | 9,351,000 | 1.35 | 1.31 | 4 |
| Nov 14, 2022 | $ 170.25 | $ 173.26 | $ 170.25 | $ 171.91 | +2.66 | 6,581,500 | 0.94 | 0.93 | |
| Nov 11, 2022 | $ 172.73 | $ 173.11 | $ 166.82 | $ 169.25 | -5.22 | 11,066,800 | 1.57 | 1.56 | 9 |
| Nov 10, 2022 | $ 174.35 | $ 174.77 | $ 172.04 | $ 174.47 | +2.02 | 7,877,500 | 1.17 | 1.12 | 3 |
| Nov 09, 2022 | $ 174.27 | $ 175.00 | $ 172.34 | $ 172.45 | -1.39 | 6,150,000 | 0.92 | 0.87 | 2 |
| Nov 08, 2022 | $ 173.13 | $ 174.69 | $ 172.18 | $ 173.84 | +0.86 | 5,148,400 | 0.78 | 0.73 | |
| Nov 07, 2022 | $ 171.67 | $ 173.85 | $ 171.44 | $ 172.98 | +1.50 | 6,621,000 | 1.00 | 0.94 | 6 |
| Nov 04, 2022 | $ 171.56 | $ 172.50 | $ 169.24 | $ 171.48 | +0.76 | 5,300,500 | 0.80 | 0.75 | 4 |
| Nov 03, 2022 | $ 169.81 | $ 171.47 | $ 168.94 | $ 170.72 | +0.29 | 4,819,900 | 0.73 | 0.68 | 1 |
| Nov 02, 2022 | $ 172.89 | $ 173.94 | $ 170.29 | $ 170.43 | -2.66 | 6,877,300 | 1.03 | 0.96 | 1 |
News
The latest news about Johnson & Johnson (JNJ).
GuruFocus | 2022-11-30 17:31:29
Amid rising concerns about the state of the global economy, rising inflation, central bank interest rate hikes and increased Covid-19 restrictions in China, marked indexes were mixed on Wednesday morning.
CNBC Television | 2022-11-30 10:37:36
CNBC's Jim Cramer and the 'Squawk on the Street' team discuss a new report that Horizon Therapeutics is in preliminary talks with major pharmaceutical companies over a potential takeover.
Investors Business Daily | 2022-11-30 08:00:38
Most S&P 500 investors got a little gain this month. But investors willing to look off the beaten path found huge gains.
Investors Business Daily | 2022-11-29 17:38:41
Horizon said Tuesday it's considering potential offers from three Big Pharma stalwarts, sending HZNP stock soaring more than 30% after hours. The post Horizon Therapeutics Rockets As It Considers Potential Bids From Amgen, J&J, Sanofi appeared first on Investor's Business Daily.
Forbes | 2022-11-29 13:05:47
World Wresting Entertainment, J&J Snack Foods and Ulta Beauty Inc are having a great year if you go by stock price increase.
CNBC Television | 2022-11-29 08:12:26
Sarat Sethi, managing partner and portfolio manager at DCLA, joins CNBC's 'Squawk Box' to break down potential market strategies and stocks to watch ahead of the open. Sethi also breaks down how he's navigating markets amid uncertainty around China and its zero-Covid strategy.
Stockmarketcom | 2022-11-28 15:12:48
2 top health care dividend stocks to check out ahead of December 2022.
Earnings
| Date | Time | EPS Expected | EPS Reported | % | Revenue Expected | Revenue Reported | % |
|---|---|---|---|---|---|---|---|
| 2022-10-18 | BMO | 2.47 | 2.55 | 3.23% | -- | -- | -- |
| 2022-07-19 | BMO | 2.57 | 2.59 | 0.77% | 24B | -- | -- |
| 2022-04-19 | BMO | 2.56 | 2.67 | 4.29% | -- | -- | -- |
| 2022-01-25 | BMO | 2.12 | 2.13 | 0.47% | 24B | 25B | 4.19% |
| 2021-10-19 | BMO | 2.37 | 2.60 | 9.7% | 24B | 23B | -1.55% |
| 2021-07-21 | BMO | 2.28 | 2.48 | 8.77% | 24B | 23B | -2.09% |
| 2021-04-20 | BMO | 2.34 | 2.59 | 10.68% | -- | -- | -- |
| 2021-01-26 | BMO | 1.82 | 1.86 | 2.19% | -- | -- | -- |
Top Discussions
These are the top discussions over the last 24-hours that mention the JNJ stock ticker symbol.
Unusual Option Activity
Option contracts that are trading at a significantly higher volume relative to the contract's open interest. These might provide some insight into what "smart money" is doing with large volume orders.
| Type | Strike | Exp Date | DTE | Bid | Ask | Last | Volume | Open Interest | Vol/OI | IV |
|---|---|---|---|---|---|---|---|---|---|---|
| PUT | $ 175.00 | 11/03/22 | 4 | $ 1.67 | $ 1.83 | $ 1.70 | 334 | 220 | 1.52 | 0.20% |
| CALL | $ 175.00 | 11/10/22 | 11 | $ 2.66 | $ 2.85 | $ 2.69 | 2,141 | 405 | 5.29 | 0.22% |
| PUT | $ 120.00 | 11/10/22 | 11 | $ 0.00 | $ 0.75 | $ 0.03 | 40 | 16 | 2.50 | 1.08% |
| PUT | $ 125.00 | 11/10/22 | 11 | $ 0.00 | $ 0.35 | $ 0.03 | 180 | 65 | 2.77 | 0.87% |
| PUT | $ 175.00 | 11/10/22 | 11 | $ 2.41 | $ 2.67 | $ 2.83 | 262 | 15 | 17.47 | 0.20% |
| PUT | $ 105.00 | 11/17/22 | 18 | $ 0.00 | $ 0.15 | $ 0.04 | 300 | 234 | 1.28 | 0.90% |
| PUT | $ 175.00 | 11/17/22 | 18 | $ 2.84 | $ 3.05 | $ 3.20 | 5,164 | 368 | 14.03 | 0.18% |
| PUT | $ 110.00 | 11/24/22 | 25 | $ 0.00 | $ 0.04 | $ 0.03 | 636 | 12 | 53.00 | 0.62% |
| CALL | $ 185.00 | 12/01/22 | 32 | $ 0.37 | $ 0.56 | $ 0.42 | 410 | 28 | 14.64 | 0.16% |
| PUT | $ 210.00 | 01/19/23 | 81 | $ 42.60 | $ 43.95 | $ 43.94 | 51 | 26 | 1.96 | 0.58% |
| CALL | $ 250.00 | 04/20/23 | 172 | $ 0.05 | $ 0.10 | $ 0.07 | 180 | 49 | 3.67 | 0.22% |
| PUT | $ 85.00 | 04/20/23 | 172 | $ 0.00 | $ 0.40 | $ 0.05 | 201 | 94 | 2.14 | 0.53% |
| PUT | $ 170.00 | 01/16/25 | 809 | $ 15.00 | $ 16.55 | $ 15.90 | 33 | 24 | 1.38 | 0.18% |
Last Updated: Sat, 29 Oct 2022 20:37 EST
Failures to Deliver
Each point represents the aggregate net balance of shares that failed to be delivered as of a particular settlement date.
Please note that fails-to-deliver can occur for a number of reasons on both long and short sales. Therefore, fails-to-deliver are not necessarily the result of short selling, nor evidence of abusive “naked” short selling. For more information on short selling and fails-to-deliver, see Key Points About Regulation SHO, Division of Market Regulation, and Final Rule: Short Sales.
Last Updated: Tue, 14 Dec 2021 12:00 EST
@wsbdaily
wsbdaily